98 research outputs found
Bone marrow reticulocytes: a Plasmodium vivax affair?
In this issue of Blood, Malleret and colleagues show the importance of the bone marrow in Plasmodium vivax biology by proving the preferential infection of young reticulocytes (generally restricted to the bone marrow), which then experience accelerated maturation postinvasion
"Resistance" to diagnostics: A serious biological challenge for malaria control and elimination
Delay in diagnosis and treatment is the leading cause of death in malaria patients. The recommendation issued in 2010 by the World Health Organization (WHO) to reserve malaria treatment to parasitologically confirmed malaria infections has boosted the use of malaria rapid diagnostic tests (RDTs), which have now become a critical component of management and surveillance of malaria. Indeed, it has been estimated that over 280 million RDTs are now used annually, at a cost of hundreds of millions of euros [1]. Beyond their use as a diagnostic tool for patients with suspected malaria, the detection of Plasmodium antigens in blood samples is also used in in vitro tests of sensitivity to antimalarial drugs, as a marker of clinical severity and to verify the elimination of the parasite after treatment, although the decay of parasite antigens may take longer than the clearance of parasitaemia.2 p
Malaria Parasites in the Asymptomatic: Looking for the Hay in the Haystack
With malaria elimination back on the international agenda,
programs face the challenge of targeting all Plasmodium
infections, not only symptomatic cases. As asymptomatic
individuals are unlikely to seek treatment, they are missed by
passive surveillance while remaining infectious to mosquitoes,
thus acting as silent reservoirs of transmission. To estimate
the risk of asymptomatic infections in various phases of malaria
elimination, we need a deeper understanding of the underlying
mechanisms favoring carriage over disease, which may involve
both pathogen and host factors. Here we review our current
knowledge on the determinants leading to Plasmodium falciparum
symptomless infections. Understanding the host-pathogen
interactions that are most likely to affect transitions between
malaria disease states could guide the development of tools to
tackle asymptomatic carriers in elimination settings
A humanized mouse model for sequestration of Plasmodium falciparum sexual stages and in vivo evaluation of gametocytidal drugs
The development of new drugs to disrupt malaria transmission
requires the establishment of an in vivo model to address the
biology of Plasmodium falciparum sexual stages (gametocytes).
Herein we show that chemically immune-modulated NSG mice grafted
with human erythrocytes support complete sexual development of
P. falciparum parasites and generate high gametocytemia.
Immunohistochemistry and RT-qPCR analyses indicate an enrichment
of immature gametocytes in the bone marrow and the spleen,
suggesting a sequestration mechanism reminiscent to that
observed in humans. Upon primaquine treatment, elimination of
gametocytes from peripheral blood and from sequestration sites
was observed, providing a proof of concept that these mice can
be used for testing drugs. Therefore, this model allows the
investigation of P. falciparum sexual commitment, gametocyte
interactions with the bone marrow and spleen and provides the
missing link between current in vitro assays and Phase I trials
in humans for testing new malaria gametocytidal drugs
Analytical sensitivity of current best-in-class malaria rapid diagnostic tests
BACKGROUND: Rapid diagnostic tests (RDTs) are today the most
widely used method for malaria diagnosis and are recommended,
alongside microscopy, for the confirmation of suspected cases
before the administration of anti-malarial treatment. The
diagnostic performance of RDTs, as compared to microscopy or PCR
is well described but the actual analytical sensitivity of
current best-in-class tests is poorly documented. This value is
however a key performance indicator and a benchmark value needed
to developed new RDTs of improved sensitivity. METHODS: Thirteen
RDTs detecting either the Plasmodium falciparum histidine rich
protein 2 (HRP2) or the plasmodial lactate dehydrogenase (pLDH)
antigens were selected from the best performing RDTs according
to the WHO-FIND product testing programme. The analytical
sensitivity of these products was evaluated using a range of
reference materials including P. falciparum and Plasmodium vivax
whole parasite samples as well as recombinant proteins. RESULTS:
The best performing HRP2-based RDTs could detect all P.
falciparum cultured samples at concentrations as low as 0.8
ng/mL of HRP2. The limit of detection of the best performing
pLDH-based RDT specifically detecting P. vivax was 25 ng/mL of
pLDH. CONCLUSION: The analytical sensitivity of P. vivax and Pan
pLDH-based RDTs appears to vary considerably from product to
product, and improvement of the limit-of-detection for P. vivax
detecting RDTs is needed to match the performance of HRP2 and Pf
pLDH-based RDTs for P. falciparum. Different assays using
different reference materials produce different values for
antigen concentration in a given specimen, highlighting the need
to establish universal reference assays
Molecular surveillance of pfhrp2 and pfhrp3 deletions in Plasmodium falciparum isolates from Mozambique
BACKGROUND: Malaria programmes use Plasmodium falciparum
histidine-rich protein-2 (PfHRP2) based rapid diagnostic tests
(RDTs) for malaria diagnosis. The deletion of this target
antigen could potentially lead to misdiagnosis, delayed
treatment and continuation of active transmission. METHODS:
Plasmodium falciparum isolates (n = 1162) collected in Southern
Mozambique were assessed by RDTs, microscopy and/or 18SrRNA
qPCR. pfhrp2 and pfhrp3 deletions were investigated in isolates
from individuals who were negative by RDT but positive by
microscopy and/or qPCR (n = 69) using gene-specific PCRs, with
kelch13 PCR as the parasite DNA control. RESULTS: Lack of pfhrp2
PCR amplification was observed in one of the 69 isolates
subjected to molecular analysis [1.45% (95% CI 0.3-7.8%)].
CONCLUSIONS: The low prevalence of pfhrp2 deletions suggests
that RDTs will detect the vast majority of the P. falciparum
infections. Nevertheless, active surveillance for changing
deletion frequencies is required
Mosquitoes as a feasible sentinel group for anti-malarial resistance surveillance by Next Generation Sequencing of Plasmodium falciparum
Background: Plasmodium falciparum drug resistance surveillance is key to successful disease control and eradication.
Contemporary methods that only allow determination of prevalence of resistance are expensive, time consuming
and require ethical considerations. A newer method involving Next Generation Sequencing (NGS) permits obtaining
frequency of resistance while allowing to detect minority variants in mixed infections. Here, NGS was tested for P. falciparum resistance marker detection in mosquito samples as a feasible and suitable alternative for molecular resistance
surveillance. Anopheles funestus were collected in southern Mozambique using CDC light traps and manual collec‑
tions. DNA was extracted from either whole mosquito, head-thorax and abdomen separately or pools of fve mosqui‑
toes. These samples were screened for P. falciparum and if positive for k13, pfcrt, pfmdr1, pfdhps and pfdhfr mutations
related to anti-malarial drug resistance with Sanger sequencing and NGS.
Results: Among the 846 samples screened for P. falciparum, 122 were positive by 18S ssrDNA qPCR with an infection
rate of 23.6%. No mutations were observed for k13 and pfcrt72-76 and almost zero for pfmdr86, but quintuple pfdhfr/
pfdhps mutations were near fxation and about half of the isolates contained the pfmdr184F polymorphism. Similar
allele frequencies of resistance markers were estimated with NGS in comparison with the prevalence of markers
obtained with the gold standard Sanger sequencing.
Conclusions: Pooled deep sequencing of P. falciparum isolates extracted from mosquitoes is a promising, efcient
and cost-efective method to quantify allele frequencies at population level which allows to detect known and
unknown markers of resistance in single and mixed infections in a timelier manner. Using mosquitoes as sentinel
group and focusing on allele frequency opposed to prevalence, permits active surveillance across a more homogene‑
ous geographical range
Dynamics of Afebrile Plasmodium falciparum Infections in Mozambican Men
Background: Afebrile Plasmodium falciparum infections usually
remain undetected and untreated in the community and could
potentially contribute to sustaining local malaria transmission
in areas aiming for malaria elimination. Methods: Thirty-two men
with afebrile P. falciparum infections detected with rapid
diagnostic test (RDTs) were followed for 28 days. Kaplan-Meier
estimates were computed to estimate probability of parasite
positivity and of reducing parasitaemia by half of its initial
level by day 28. Trends of parasite densities quantified by
microscopy and qPCR were assessed using Poisson regression
models, and the microscopy to qPCR positivity ratio was
calculated at each time point. Three survival distributions
(Gompertz, Weibull, and gamma) were used to evaluate their
strength of fit to the data and to predict the median lifetime
of infection. Results: The cumulative probability of parasite
qPCR positivity by day 28 was 81% (95% CI 60.2-91.6). Geometric
mean parasitemia at recruitment was 516.1 parasites/muL and fell
to <100 parasites/muL by day 3, reaching 56.7 parasites/muL
on day 28 (p-value<0.001). The ratio of P. falciparum
positive samples by microscopy to qPCR decreased from 0.9 to
0.52 from recruitment to day 28. The best model fit to the data
was obtained assuming a Gompertz distribution. Conclusions:
Afebrile P.falciparum infections detectable by RDT in
semi-immune adults fall and stabilize at low-density levels
during the first four days since detection, suggesting a rapid
decline of potential transmissibility in this hidden parasite
reservoir
Community-informed research on malaria in pregnancy in Monrovia, Liberia: a grounded theory study
Background: Liberia is a West African country that needs substantial investment to strengthen its National Malaria
Control Programme (NMCP), which was disrupted during the 2014–2016 Ebola epidemic. As elsewhere, Liberian
pregnant women are especially vulnerable to malaria. Understanding prevention and treatment-seeking behaviours
among the population is crucial to strategize context-specifc and women-centred actions, including locally-led
malaria research, to improve women’s demand, access and use of NMCP strategies against malaria in pregnancy.
Methods: In 2016, after the Ebola crisis, a qualitative inquiry was conducted in Monrovia to explore populations’
insights on the aetiology, prevention and therapeutics of malaria, as well as the community and health workers’
perceptions on the utility of malaria research for pregnant women. In-depth interviews and focus group discussions
were conducted among pregnant women, traditional community representatives and hospital staf (n=38), using a
feminist interpretation of grounded theory.
Results: The narratives indicate that some Liberians believed in elements other than mosquito bites as causes
of malaria; many had a low malaria risk perception and disliked current efective prevention methods, such as
insecticide-treated nets; and some would resort to traditional medicine and spiritual care to cure malaria. Access to
clinic-based malaria care for pregnant women was reportedly hindered by lack of fnancial means, by unofcial user
fees requested by healthcare workers, and by male partners’ preference for traditional medicine. The participants
suggested that malaria research in Liberia could help to design evidence-based education to change current malaria
prevention, diagnostic and treatment-seeking attitudes, and to develop more acceptable prevention technologies.
Conclusion: Poverty, insufcient education on malaria, corruption, and poor trust in healthcare establishment are
structural factors that may play a greater role than local traditional beliefs in deterring Liberians from seeking, access‑
ing and using government-endorsed malaria control strategies. To increase access to and uptake of preventive and
biomedical care by pregnant women, future malaria research must be informed by people’s expressed needs and
constructed meanings and values on health, ill health and healthcare
Effects of HIV infection on maternal and neonatal health in southern Mozambique: A prospective cohort study after a decade of antiretroviral drugs roll out
INTRODUCTION: The HIV epidemic is concentrated in sub-Saharan
Africa. However, limited information exists on its impact on
women and infant's health since the introduction of
antiretroviral drugs in this region, where health resources are
often scarce. METHODS: The effect of HIV infection on maternal
health, birth outcomes and infant health was analysed in two
contemporary cohorts of HIV-uninfected and HIV-infected pregnant
women from southern Mozambique. Pregnant women attending the
first antenatal care visit were followed until one month after
delivery. Antiretroviral therapy was administered based on CD4+T
cell count and clinical stage. Maternal and neonatal morbidity
and mortality, as well as pregnancy outcomes were assessed by
mother's HIV status. RESULTS: A total of 1183 HIV-uninfected and
561 HIV-infected pregnant women were enrolled. HIV-infected
women were more likely to have anaemia both at the first
antenatal care visit and at delivery than HIV-uninfected women
(71.5% versus 54.8% and 49.4% versus 40.6%, respectively,
p<0.001). Incidence of hospital admissions during pregnancy
was increased among HIV-infected women (RR, 2.04, [95%CI, 1.45;
2.86]; p<0.001). At delivery, 21% of HIV-infected women
reported being on antiretroviral therapy, and 70% having
received antiretroviral drugs for prevention of mother to child
transmission of HIV. The risk of stillbirths was doubled in
HIV-infected women (RR, 2.16 [95%CI 1.17; 3.96], p = 0.013).
Foetal anaemia was also increased among infants born to
HIV-infected women (10.6% versus 7.3%, p = 0.022). No
differences were found in mean birth weight, malaria,
prematurity and maternal and neonatal deaths between groups.
CONCLUSIONS: HIV infection continues to be associated with
significant maternal morbidity and poor neonatal health
outcomes. Efforts should urgently be made to identify the
barriers that impede improvements on the devastating effects of
HIV in African women and their infants. TRIAL REGISTRATION:
ClinicalTrials.gov NCT 00811421
- …